Showing results (41-50 of 51) with videos related to
Sort By:
Pageof 6
Molecular & Cellular Proteomics : MCP|September 22, 2012
Identification of new autoantigens by protein array indicates a role for IL4 neutralization in autoimmune hepatitisChiara Zingaretti, Milena Arigò, Angela Cardaci, et al.Journal of Clinical Medicine|October 16, 2024
Safety of Sofosbuvir-Based Direct-Acting Antivirals for Hepatitis C Virus Infection and Direct Oral Anticoagulant Co-AdministrationValerio Rosato, Riccardo Nevola, Marcello Dallio, et al.Journal of Viral Hepatitis|July 29, 2024
Hepatitis C epidemiology and treatment outcomes in Italy: Impact of the DAA era and the COVID-19 pandemicMaria Paola Tramonti Fantozzi, Luca Ceccarelli, Davide Petri, et al.JHEP Reports : Innovation in Hepatology|July 24, 2023
Lower pretreatment HBV DNA levels are associated with better off-treatment outcomes after nucleo(s)tide analogue withdrawal in patients with HBeAg-negative chronic hepatitis B: A multicentre cohort studyMilan J Sonneveld, Shao-Ming Chiu, Jun Yong Park, et al.Current Medical Research and Opinion|May 31, 2018
Epidemiological, demographic and clinical data on chronic viral hepatitis C in TuscanyCristina Stasi, Caterina Silvestri, Roberto Berni, et al.World Journal of Hepatology|May 31, 2018
Clinical epidemiology of chronic viral hepatitis B: A Tuscany real-word large-scale cohort studyCristina Stasi, Caterina Silvestri, Roberto Berni, et al.Cancers|October 14, 2023
Vessel-Guided Mesohepatectomy for Liver Partition and Staged Major Parenchyma-Sparing Hepatectomies with Super-Selective Portal Vein Embolization or Enhanced ALPPS to Achieve R0 Resection for Colorectal Liver Metastases at the Hepatocaval ConfluenceLucio Urbani, Nicolò Roffi, Roberto Moretto, et al.Gastroenterology|September 28, 2023
HBV DNA and HBsAg Levels at 24 Weeks Off-Treatment Predict Clinical Relapse and HBsAg Loss in HBeAg-Negative Patients Who Discontinued Antiviral TherapyMilan J Sonneveld, Shao-Ming Chiu, Jun Yong Park, et al.Expert Review of Anti-Infective Therapy|December 25, 2018
Real life experiences in HCV management in 2018Mauro Viganò, Massimo Andreoni, Carlo Federico Perno, et al.Liver International : Official Journal of the International Association for the Study of the Liver|September 4, 2025
Diagnosed Patients With Chronic Hepatitis B and Delta Virus in Italy in 2024: An Estimation From a National Real-World DatabaseAlessandro Loglio, Ivan Gardini, Massimiliano Conforti, et al.Pageof 6